Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA) ; day:6 ; month:2 ; year:2017 ; pages:1-8
Journal of neurology ; (6.2.2017), 1-8
- Creator
-
DiPaolo, Giovanni
- Contributor
-
Jimenez-Moreno, Cecilia
Nikolenko, Nikoletta
Atalaia, Antonio
Monckton, Darren G.
Guglieri, Michela
Lochmüller, Hanns
SpringerLink (Online service)
- DOI
-
10.1007/s00415-017-8399-x
- URN
-
urn:nbn:de:1111-201703025665
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- DiPaolo, Giovanni
- Jimenez-Moreno, Cecilia
- Nikolenko, Nikoletta
- Atalaia, Antonio
- Monckton, Darren G.
- Guglieri, Michela
- Lochmüller, Hanns
- SpringerLink (Online service)
Other Objects (12)
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Disease burden of myotonic dystrophy type 1
Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
Health-related quality of life in patients with adult-onset myotonic dystrophy Type 1: a systematic review
Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations
Analysis of the functional capacity outcome measures for myotonic dystrophy
Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy
Change over time in ability to perform activities of daily living in myotonic dystrophy type 1
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Disease burden of myotonic dystrophy type 1
Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
Health-related quality of life in patients with adult-onset myotonic dystrophy Type 1: a systematic review
Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations
Analysis of the functional capacity outcome measures for myotonic dystrophy
Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy
Change over time in ability to perform activities of daily living in myotonic dystrophy type 1
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Disease burden of myotonic dystrophy type 1
Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
Health-related quality of life in patients with adult-onset myotonic dystrophy Type 1: a systematic review
Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations
Analysis of the functional capacity outcome measures for myotonic dystrophy
Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy